Anda di halaman 1dari 7

Jurnal translet

Mrs. TA, 28 year old and married since 1 year, was anxious to conceive due to her irreg
ular cycles as a result of PCOS. Her age at menarche was 12 years, with menstrual cycle
s being irregular for 1-2 days every 35-45 days. She also had a history of premenstrual
pain, and tension and spotting with dysmenorrhea. She had undergone ureteroscopy f
or renal calculi twice. She also had a family history of hemophilia with two of her broth
ers being affected and her mother was a carrier. Her three maternal uncles also had he
mophilia.
She was obese with moderate hirsutism. Clinically, her uterus was normal sized, firm, a
nd mobile with al I fornices being clear. At her baseline ultrasound, the uterine size wa
s 70.6/ 33.2/42.2 mm; endometrial thickness was 6.1 mm; both ovaries were enlarged
with multiple follicles and increased stroma.
Her baseline hormone levels on day 2 of the cycle were as follows: follicle stimulating h
ormone (FSH)-5.6 mIU/ml, luteinizing hormone (LH)-5.3 mIU/ml, dehydroepiandro sulf
ate (DHEAS)-780 ng/ml, androstenidione-2.7 ng/ ml, estradiol (E2)-20.73 pg,/ml, proge
sterone (P4)-3.68 ng/ml, thyroid stimulating hormone (TSH)-9.4 uRJ/ml, free T4 (FT4)-1
.25, fasting insulin (FI)-15.8 uU/mI. Fasting Insulin levels were repeated after 3 months
of Metformin (500 mg twice a day) which were 3.1 Semen analysis done was normal.
In view of the family history of haemophilia, she was evaluated to rule out a carrier sta
te. Her prothrombin time (PT) was 13.2 s (control 12 s), activated part ialthromboplas t
in time (aPTT) 33 s (control 30 s), factor VIII c activity S6% (60-150), factor IX c assay - 6
0% (60-150), and factor XIII screening showed stable clot. Her results for PCR for carrie
r state revealed that she was not a carrier for hemophilia. Her hysterosalphingography
(HSG) showed a normal uterine cavity with a good filling of both tubes with the bilater
al spill. The right tube was morphologically normal with mild dilatation and clumping of
the distal end of the left tube. Tubal pressures were low.
She was started on 511 )1g of tablet eltroxin and tablet metrofin 50(1 mg BD. Metform
in was discontinued after 2 months due to gastrointestinal side effects.
11w first cycle was monitored without 01 drugs, with no ovulation documented after
monitoring till day 21 of the cycle. In the second cycle, clomiphene citrate (CC) 100 mg
was given from days 2 to 6, and ovulation was documented on day 22.1n the next two
cycles, the dose of CC was increased to 150 mg. Ovulation was documented on days 15
and 17. In the next three cycles letnyzole 5 mg was given from days 3 to 7, and ovulati
on was documented on day 14 or 15 of the cycle. As there was no pregnancy even with

letrazole, CC was given again in the seventh cycle. She had three mature follicles on da
y 12, when KC 5000 IL was given intramuscular, and ovulation was documented on day
s 14 and 15. Micronized progesterone vaginal pessaries were given for In teal support.
A total at 20 days alter ovulation, Il-hUG dune on November 19, 2007, was 410 mil:init.
11-1)CG was repeated again on November 22, 2007, which had increased to 1085 milit
ia USG revealed a single intrauterine (I U) sac with a gestational sac diameter (C,SD) of
4.4 mm (5 weeks 1 day).
On November 26, 2007, a repeat TVS did not show any increase in GSD (5.13 mm - 5 w
eeks 2 days). No yolk sac or fetal pole was seen. Repeat TVS after a week on December
3, 2007, documented a gestational sac of 8.4 net (5 weeks 4 days) with no yolk sac or f
etal pole seen. There was minimal tenderness in the right fomix, but no ectopic gestati
onal sac (GS) seen in either fomix. The 13-KG level on that day was 9515 which was too
high for an anembryonic pregnancy it-hce was repeated on December 6, 2C07, and W
AS 11342 mfUltrd; WS documented a GS of 10.5 nun (5 weeks 6 days) with no fetal pol
e or yolk sac seen. There was another small GS seen measuring 4 mm . There were also
two small sacs measuring 4 and 6 mm, seen in the right adenexa, the left adenexa app
earing normal with no free fluid in POD. There was no abdominal tenderness or guardi
ng or tenderness in all fornices. On December 8, 2007, the p-hCG was 12947 mIU/ ml
with IU GS of 10.5 mm (5 weeks 6 days) with no fetal pole or yolk sac The two sacs in t
he right adenexa had increased in size to 8 and 6 mm, respectively. There was no free f
luid in POD. The patient was clinically asymptomatic and stable so a decision to start m
edical therapy was taken. Inj MTX 1 mg/kg was given IM with inj. leucovorine 0.1/kg gi
ven IM on alternate days.
The patient was followed up on a regular basis clinically and by TVS. She was also closel
y monitored for -hCG, hemoglobin (HB), complete blood count (CBC), liver function te
st (LFT), and peripheral smears.
The (3-hCG levels after MTX injection were as follows:
December 12, 2007, 11,967 mIU/ml
December 14, 2007, 10,164 mIU/m1
December 17, 2007, 6292 mIU/m1
December 20, 2007, 3232 mIU/ml
December 22, 2007, 1088 mIU/ml
December 24, 2007, 791 mIU/m1
December 28, 2007, 90 mIU/m1

January 2, 2008, 9 mIU/ml.


Serial TVS done showed regression of intrauterine and right adenexal sacs. Once the
hCG levels were less than 1000 mIU/ml, the patient had per vaginal bleeding. TVS sho
wed the products in the cervical canal which were then removed under aseptic precaut
ions.
A total of six injections of MTX were given. All her blood parameters were normal thro
ughout the treatment.
Once j3-hCG was below 10 mIU/ml, she was advised not to conceive for 6 months, wit
h follow-up of p-hCG after 1 and
2 months which was normal.
After 6 months, she was again given CC for OI, and ovulation was documented on day
15. She conceived in the second treatment cycle with timed intercourse. Her -hCG 20 d
ays after ovulation was 3571 mIU/ml with an IU GS of 9 mm corresponding to 5 weeks
3 days seen on TVS. Corpus luteum was seen on the right side with no other adenexal
pathology. Repeat -hCG after 1 week was 15,000 mIU/m1. A gestational sac with yolk
sac and fetal pole corresponding to 6 weeks and 5 days was seen. Fetal heart was also
documented. She had a normal vaginal delivery at 39 weeks of gestation. She delivered
a female baby weighing 3.4 kg.
Case 2
Mrs SS presented with secondary infertility for 6 months. She had a full-term normal d
elivery female baby aged 4.5 years alive and health); after which she used harrier contr
aception fur 3 years and IUCD for 1.5 years for spacing. 1-15G done outside on Februar
y 7, 2007, showed right tubal block with the left tube filling poorly. Cannulation was do
ne under fluoroscopic guidance, after which both the tubes showed free spill. Endomet
rium was positive Ibr tuberculosis PCR. She had undergone four cycles of ovulation ind
uction, two citrate and two with gonad otrophias. She ovulated in all the cycles but her
endometrium was thin and lesser than 7.5 mm in all four cycles.
Her first scan done at our clinic was on day 19 of the menstrual cycle. The uterus was n
ormal, but the endometrium was only 7.R nun thick. Both ovaries were normal with a v
olume of 4.96 and 4.20 cm and an antral follicle count (AFC} of seven. With this histor
y and investigation report, the patient was planned for 01 with RH. Two cycles of Ur w
ere performed with tablet I .Ct razolc 5 mg, given from days 3-7. The dermal applicatio
n of EstroGel was done once the follicles were 16 mm for the treatment of thin endo
metrium. The ovulation occurred on days 13 and 15. The endometrial thickness on the

day of 1111 was 12.8 and 12.3 mm. We did two inure cycles of 1U1 with gonad ot roph
ins. Ovulation was documented on days 11 and 14 of the cycle and the endometrial thi
ckness was 11.6 and 11.1 mm. As there was no pregnancy, the patient was counselled
for in vitro teriilizatinn ([VF). Hysteroscopy was done prior to JIFF, which revealed adhe
sions at the &MILLS and both cornu. The codonwtrium was fibrotic and pearly white in
color except for a small portion oil the :Interior wall. he cavity was stnaller Ohm Hun m
at in size. Adhesiolysis was done and the patient was put on conjugated estrogen (Pre
marin) 1.25 mg twice a day for 25 days with medrosyprogesterone 10 mg twice a day f
or the last ID days. This hormone replacement therapy (I IRT) was given for 3 months.
A repeat hysteroscopy done after 3 months revealed reformation of adhesions at the Il
unduS which were rut using scissors and Fifa given again for 3 months. Before IVF, hys
teroscopy did not show any adhesions but the endometrium was thin and fibrotic on t
he posterior wall.
The protocol used fur IVF was long luteal down-regulation from day 21 with gunadotro
phins started on day 3 of the gels when the cstradiol was 18 pg/MI and progesterone
was 1.15 ng/ml. She was started on urinary FSH 30U 1U and as the estradiol level on d
ay 8 of the cycle was 6 pg/ nil and the tollicular size was 8-12 mm, the dose was increas
ed by 75 Hi and continued till day 13. On day 14, Rec. hCG 250 meg will; given subcuta
neously when there were SIX follicles 16-18 mm in d iameter. On the day tit heG, estra
diol was 3265 pg/ml and progesterone was 2.8 ng/ml. Oocyte retrieval was done 35 h l
ater. Luteal phase support was given with intramuscular inj. Gestone 100 mg (Ferring P
harmaceuticals, India). The luteal phase was monitored for ovarian hyperstimulation sy
ndrome (OHSS). Ten days after ET, -hCG was 53 mIU/m1 and a repeat level after 7 da
ys was 1030 mIU/ml. At that time, a single gestational sac was seen with a mean gestat
ional sac diameter (MGSD) of 4.5 mm corresponding to 5 weeks and 1 day. Two days la
ter, the patient complained of minimal bleeding per vaginum. The -hCG level was 125
8 mIU/ml, the MGSD was 4.6 mm and both adenexa showed multiple corpora lutea. N
o gestational sac was seen in the adenexa. One week later, the MGSD had increased to
8.5 mm which corresponded to 5 weeks and 5 days, but no fetal pole was seen and th
e bleeding had stopped. Despite the increase in the MGSD, there was no correspondin
g increase in the p-HCG levels which were 1567 mIU/ml. Two days later, the patient ha
d three syncopal attacks. On examination, the vitals were normal but there was tender
ness in the right iliac fossa and fornix. On TVS, the IU sac with yolk sac was seen, but th
ere was also a complex mass of 90 x 70 mm in the right adenexa with free fluid in POD,

which was turbid. Diagnosis of right EP with coexisting IU pregnancy was made. In vie
w of an IU pregnancy and right adenexal mass, the decision for laparoscopy was taken.
At laproscopy, right partial salpingectomy for ruptured EP was done. One week later, t
he TVS showed a irregular gestational sac with MGSD of 5.8 min and the p-hCG level w
as 820 mIU/ml. The repeat hCG level after 5 days was 418 mIU/m1 and the gestational
sac had not increased in size. Decision for a curettage was taken. One week later, the p
-hCG level was 5 mIU/ml. A frozen embryo transfer was done in a natural cycle, and a b
iochemical pregnancy was documented with the 3-hCG level going to 378 mIU/ml.

VM, seorang wanita 34 tahun menikah sejak 14 tahun, disajikan kepada kita pada tahu
n 2004 dengan infertilitas primer. Siklus nya adalah dari 7-15 hari setiap 45-60 hari. HS
G nya dilakukan pada tahun 1994 adalah normal. Masa lalu analisis semen Suaminya m
enunjukkan oligoasthenospermia berat dengan hitungan 6 juta dan motilitas 22%. Pem
eriksaan panggul normal dan pada TVS, rahim adalah 78 x 43 x 58 mm; kedua ovarium
normal dengan jumlah folikel antral dari 5. Kanan adenexa mengungkapkan hidrosalpi
ng a. Keputusan untuk hysterolaparoscopy diambil. Pada histeroskopi, ada polip di din
ding lateral kiri yang dipotong. Ostia, kornu, fundus, rongga, dan enciometrium normal
. Pada laparoskopi, rahim, tabung, dan ovarium yang normal. Tabung yang tepat memil
iki kista paratubal besar yang mensimulasikan hidrosalping di TVS. Pada hari 2, tes hor
mon dilakukan dengan hasil sebagai berikut: FSH-3.5 m1U / m1; LH-2.2 mIU / m1; prol
aktin -21,4 ng / ml; TSH-3.3 uIU / ml. Pasien diinginkan dua siklus IUI, yang dilakukan d
engan CC 150 mg dari hari 2 sampai 6 dari MC.
Dia mengembangkan satu folikel dominan, di sebelah kanan pada siklus I, dan di sebela
h kiri pada siklus kedua. Saat ia gagal untuk hamil, ICSI direncanakan. Pada hari 2, estra
diol (U) adalah 36,6 pg / ml dan progesteron 1,4 mg / ml. Stimulasi ovarium terkontrol
(COS) dimulai dengan FSH 150 IU dan 75 IU IINIC. Pada hari ke-5, tingkat E2 adalah 33.6
dan hanya satu folikel dari enam '. 8.3 mm WAS Remaja di sisi kiri. The IIMG dosis ditin
gkatkan menjadi 150 Ill. Pada hari 10 dari COS, hanya ada satu folikel 10,5 mm ukuran
dan tingkat E2 adalah 34 pg / mI. Keputusan untuk membatalkan siklus itu diambil dan
darah untuk AMR dikirim. Nilai-nilai AMH adalah 0.04 / lib ml. 1 dia keputusan untuk s
umbangan oosit diambil sebagai cadangan ovarium miskin. Sumbangan Oocote adalah
klon dalam GnRH agonis protokol panjang siklus HRT. Tiga kelas 1 embrio dua 10-sel da
n satu dipindahkan. Pertama tingkat p-ICG 14 hari setelah ET adalah 68 mIU / ml. Delap
an hari kemudian, tingkat-b hcg adalah 9781 mIU / m1 dan kantung kehamilan berukur

an 4 x 3,3 mm 3,8 sesuai dengan 5 minggu 2 hari terlihat, tapi kantung ditempatkan di
bagian bawah rongga rahim (kehamilan serviks) . Lima hari kemudian, ', ia datang deng
an bercak; yang MUSD adalah 6,6 mm, dengan yolk sac dilihat tapi tidak ada tiang janin
. 'The (4-110: tingkat adalah 11,875 mIU / m1 yang dikurangi menjadi 9.781 setelah 2 h
ari, dan un TVS, kantung di bagian bawah rahim memperluas ke leher rahim tidak terat
ur dalam ukuran Mengingat kehamilan serviks,. bergantian dengan leucovorin diberika
n. Butuh waktu hampir 2 bulan untuk fi-ha; tingkat mencapai 10 colt / ml. "Siklus kedu
a donasi oosit lagi-lagi dune 10 bulan kemudian dalam siklus I IIZT sebagai pasien seda
ng menstruasi. Kali ini kami melakukan hari 5 Transfer dan dua blastosis diperluas kelas
4 AA dipindahkan. Yang pertama ii-nya, tingkat setelah 1,0 hari adalah 134 mIU / m1 d
an .second satu 7 hari kemudian adalah 1168 int U / ml. Meskipun ha beta: makhluk> 1
000 mIU / ml, ada kantung intrauterine terlihat. Lima hari kemudian, dia datang denga
n rasa sakit di perut bagian bawah, pusing, dan muntah. Parameter penting nya yang n
ormal, dan tidak ada 'nyeri tekan abdomen dan kekakuan. Di TVS, ketebalan endometri
um adalah 20 mm tanpa kantung kehamilan; kantung kecil divisualisasikan dalam aden
exa yang tepat, meskipun tidak ada pemeriksaan nyeri. The-b hCG tingkat itu adalah 56
64 mIU / ml. Keputusan untuk terapi medis diambil dan dia sudah memulai MTX 1 mg /
kg bolak dengan leucovorin. Sebanyak empat dosis diberikan. Kali ini juga, butuh 50 ha
ri untuk tingkat menjadi negatif. Lima bulan kemudian, siklus lain dari sumbangan oosit
dilakukan dalam siklus I IRT. Dua kelas 1 delapan sel bendung embrio yang ditransfer.
Kali ini juga, leer pertama tingkat-b hCG positif, dan 1 minggu kemudian, meningkat m
enjadi 1.359, dan kantung kehamilan IU sesuai dengan S minggu dan 3 hari divisualisasi
kan. Sayangnya dia punya aborsi terjawab pada 7 minggu kehamilan dengan jantung ja
nin pertama menjadi lambat selama 2 hari, dan yang kemudian berhenti. Sebuah abors
i medis dilakukan. Pada Juni 2011, tingkat FSH-nya pada hari 2 adalah 0.44 dan LH adal
ah 0,01; satu siklus lebih dari COH dengan FSH150 TU + hMG 300 IU diadili. Tidak ada p
ertumbuhan folikel terlihat setelah 10 hari dengan tingkat E2 dari 24 pg / ml; sehingga
siklus itu dibatalkan. Setelah satu bulan, satu lagi siklus sumbangan oosit dilakukan. Itu
adalah hari 3 Transfer mana satu 10-sel grade A dan satu 8-cell kelas B blastokista

Tujuan: Profilaksis Asiklovir jangka panjang (ACV) , dianjurkan untuk mencegah her
pes simplex virus berulang Tipe 1 (HSV-1) dapat menimbulkan risiko untuk ACV-refra
ctory disease karena resisten ACV. Kami menentukan pengaruh profilaksis ACV pada p
revalensi HSV-1 resisten ACV(ACVr) kornea dan konsekuensi klinis
daripadanya pada pasien dengan Keratitis HSV-1 berulang (RHK).

Metode. Frekuensi virus resisten ACV ditentukan pada 169 kornea HSV-1 isolat dari 7
8 pasien RHK dengan riwayat penyakit stroma. Profil kerentanan ACV isolat berkorelas
i dengan parameter klinis untuk
mengidentifikasi faktor risiko predisposisi dari RHK resisten ACV
Hasil. HSV-1 kornea isolat dengan> 28% virus resisten ACV yang didefinisikan sebag
ai ACVr isolat. Empat puluh empat isolat (26%) adalah resisten ACV. Analisis multivar
iat mengidentifikasi ACV profilaksis jangka panjang (12 bulan) (rasio odds [OR] 3,42
; 95% confidence interval [CI], 1,32-8,87) dan durasi ulangan45 hari (OR 2.23; 95%
CI, 1.02- 4,87), menunjukkan ACVrefractory disease, sebagai faktor risiko independen
untuk ACVr isolat. Selain itu, kornea ACVr Isolat adalah faktor risiko untuk penyakit A
CV-refractory diseasea (OR 2.28; 95% CI, 1,06-4,89).
Kesimpulan. Data menunjukkan bahwa ACV profilaksis jangka panjang merupakan pr
edisposisi ACV refractory disease karena munculnya HSV-1 kornea resistan ACV. Pen
gujian kerentanan ACV dijamin selama follow up pasien RHK.
Herpes simplex virus tipe 1 (HSV-1) adalah human
alpha-herpes virus yang endemik di seluruh dunia. Virus biasanya diperoleh pada masa
anak usia dini melalui rute orofasial, yang mengarah ke pembentukan infeksi laten seum
ur hidup neuron yang terletak di dalam ganglia trigeminal. Reactivations Intermittent m
enyebabkan virus shedding dan kadang-kadang untuk penyakit berulang [ 1 ]. HSV-1 m
enyebabkan berbagai penyakit, mulai dari
herpes labialis ringan sampai penyakit mata mengancam [ 1 ].
Infeksi HSV-1 pada kornea, disebut sebagai herpes keratitis (HK), adalah penyebab infe
ksi umum yang menyebabkan gangguan penglihatan terutama karena sifat berulang mer
eka [ 2 , 3 ]. HK
bermanifestasi sebagai keratitis epitel menular (IEK), yang
ditandai dengan replikasi virus dangkal, atau bisa
menginfeksi stroma kornea yang mendasari dan menyebabkan herpes
stroma keratitis (HSK) [ 2 ] .Recurrent HSK dapat mengakibatkan kebutaan kornea 4 ].

Permulaan dari keratitis hsv-1 yang berulang didefinisikan sebagai presentasi dari IEK y
ang dikarakteristikan dengan ulkus kornea dendritik dan geograpik atau gejala klinik y
ang terkait dengan patologi HSK, termasuk infiltrasi sel pada stroma kornea atau bilik
mata anterior dan penjarangan stroma kornea, edema, vaskularisasi, atau cornea pseu
doguttata. Akhir dari IEK yang di isolasi didefinisikan sebagai waktu penutupan komplit
dari epitelkornea, setelah pengobatan ACV topikal dihentikan. Pada HSK yang terkait d
engan kekambuhan, akhir dari kerusakan epitel HSV-1 yang timbul kembali di